We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kingspan Group Plc | LSE:KGP | London | Ordinary Share | IE0004927939 | ORD EUR0.13 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 72.80 | 72.50 | 73.10 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMKGP
RNS Number : 6530P
Kingspan Group PLC
19 February 2021
Kingspan Group Plc
Director Appointments
19 February 2021
Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, is pleased to announce the appointments of Éimear Moloney as an Independent Non-Executive Director and Paul Murtagh as a Non-Executive Director with effect from 30 April 2021.
Éimear (50) was previously a senior investment manager in Zurich Life Assurance (Irl) plc managing asset allocation and various geographic equity portfolios, and has excellent knowledge and experience of capital markets and asset management. She has a B.A. Accounting and Finance and MSc. Investment and Treasury from Dublin City University. She is a fellow of the Institute of Chartered Accountants in Ireland, and a member of the Institute of Directors in Ireland. Éimear also has strong experience in the pharma manufacturing and controls environment as a non-executive Director of Chanelle Pharmaceuticals Group. Éimear is a non-executive Director on the Boards of Hostelworld Group plc where she chairs the Audit Committee and Yew Grove REIT plc.
Paul (47) is the Chairman and CEO of Tibidabo Scientific Industries Ltd, and was formerly the Chairman and CEO of Faxitron Bioptics LLC, leading it to its successful sale in 2018. He was also formerly the Chairman of Deerland Probiotics & Enzymes Inc. He has an excellent understanding of the US market and has significant experience in the global build out of a variety of medical and biotech businesses. Previously he worked in investment banking mergers & acquisitions at Merrill Lynch & Co. in New York and Sydney. He holds a BComm International from University College Dublin, and is a non-executive director of a number of private companies.
Neither Éimear Moloney nor Paul Murtagh hold any shares in the Company.
There are no disclosures required to be made pursuant to Rules 6.6.7 (2) to (6) of the Listing Rules.
Lorcan Dowd
Company Secretary
+ 353 (0)42 9698000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOABCGDDBGBDGBI
(END) Dow Jones Newswires
February 19, 2021 02:01 ET (07:01 GMT)
1 Year Kingspan Chart |
1 Month Kingspan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions